APA (7th ed.) Citation

H, W., AJ, S., RE, W., L, W., C, C., M, B., . . . A, C. (2023). First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 77(6), 875. https://doi.org/10.1093/cid/ciad267

Chicago Style (17th ed.) Citation

H, Waalewijn, et al. "First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 77, no. 6 (2023): 875. https://doi.org/10.1093/cid/ciad267.

MLA (9th ed.) Citation

H, Waalewijn, et al. "First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 77, no. 6, 2023, p. 875, https://doi.org/10.1093/cid/ciad267.